FEROX STRATEGIES

Lobbying for ALEXION PHARMACEUTICALS, INC. · Rare Disease Pharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Jan 20, 2026

Bills named in this filing 1

Lobbying activity 1

Health Issues

Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.